Crinetics Pharmaceuticals, Inc.
CRNX
$84.70
$0.260.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.62% | 25.63% | -5.90% | -8.70% | -6.10% |
| Total Receivables | 110.40% | 859.97% | -- | -- | -- |
| Inventory | 13.84% | 51.53% | -- | -- | -- |
| Prepaid Expenses | 3.50% | 25.35% | -37.37% | 39.60% | 288.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 0.00% | -88.56% |
| Total Current Assets | -5.90% | 26.14% | -6.50% | -7.89% | -5.72% |
|
|
|||||
| Total Current Assets | -5.90% | 26.14% | -6.50% | -7.89% | -5.72% |
| Net Property, Plant & Equipment | -2.08% | -2.74% | -1.33% | -1.85% | 2.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.10% | 21.28% | 9.85% | 22.20% | 21.53% |
| Total Assets | -5.67% | 24.42% | -5.83% | -7.25% | -5.27% |
|
|
|||||
| Total Accounts Payable | 2.87% | -43.04% | 270.13% | -46.06% | 15.07% |
| Total Accrued Expenses | 15.90% | -7.92% | -8.72% | 23.49% | 26.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.75% | 0.72% | 0.75% | -2.56% | -3.97% |
| Total Finance Division Other Current Liabilities | 31.31% | 2.91% | -24.79% | -13.76% | -13.69% |
| Total Other Current Liabilities | 31.31% | 2.91% | -24.79% | -13.76% | -13.69% |
| Total Current Liabilities | 12.42% | -16.44% | 14.72% | 8.42% | 19.34% |
|
|
|||||
| Total Current Liabilities | 12.42% | -16.44% | 14.72% | 8.42% | 19.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.73% | -1.74% | -1.52% | -1.44% | -1.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.64% | 17.33% | 0.66% | 10.72% | 4.05% |
| Total Liabilities | 7.66% | -10.06% | 8.33% | 4.93% | 9.99% |
|
|
|||||
| Common Stock & APIC | 1.21% | 17.46% | 1.82% | 1.29% | 1.46% |
| Retained Earnings | -7.82% | -9.02% | -9.49% | -11.17% | -11.02% |
| Treasury Stock & Other | -86.83% | -230.41% | -15.80% | 37.97% | -24.63% |
| Total Common Equity | -6.92% | 29.09% | -7.47% | -8.48% | -6.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.92% | 29.09% | -7.47% | -8.48% | -6.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.92% | 29.09% | -7.47% | -8.48% | -6.58% |
|
|
|||||